Streetbeat News

Revenues

NVEC

NVE Corporation reported a decrease in earnings and revenue for Q3 2023 compared to the same quarter last year, with EPS at $0.87 versus $0.88 and revenue at $6.76M versus $7.4M.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:16 pm

BROS

Dutch Bros Inc. (NYSE:BROS) announced plans to expand its operations support center in Phoenix, Arizona, with the intention to relocate approximately 40% of its total support staff there by January 1, 2025. The move is strategic, aiming to strengthen the company's operations as it targets a long-term goal of over 4,000 shops. CEO Christine Barone highlighted the importance of relationships and connectivity for the brand's growth. The company will provide more details in its Q4 and Full-Year 2023 earnings call. Despite the expansion, Dutch Bros will maintain a significant presence in Grants Pass, Oregon, including its roasting facility and several support operations.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:15 pm

BTMD

Biote Corp. has updated its preliminary revenue forecast for 2023, now expecting to generate between $185M-$187M. This is a decrease from the previous forecast, which was at the lower end of the $190M-$200M range.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:08 pm

ZOM

Zomedica, a veterinary health company, has announced preliminary Q4 revenue exceeding $7M. The company also forecasts its 2023 revenue to surpass $25M. This positive financial outlook could indicate growth and stability, potentially attracting investor interest.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 9:03 pm

WNS

Analyst ratings for WNS (Hldgs) (NYSE:WNS) show mixed sentiments with a total of 3 bullish and 1 somewhat bullish ratings over the last quarter. The 12-month price targets have an average of $73.5, with a high of $80.00 and a low of $65.00, marking a decline from the previous average of $85.33. Citigroup and Barrington Research have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. WNS's financial indicators such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management are also highlighted, with the company outperforming industry benchmarks in several areas.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:00 pm

EOLS

Evolus Inc (NASDAQ:EOLS) reported Q4 2023 revenue of $61 million, a 40% Y/Y increase, surpassing consensus estimates. Full-year revenue was $202 million, exceeding guidance and consensus. For FY 2024, Evolus forecasts revenues of $255-$265 million, with positive non-GAAP operating income expected in 2025. The company plans to submit FDA applications for Evolysse products in mid-2024 and anticipates European approvals for Estyme products in 2H 2024. Analysts from Needham, HC Wainwright, Cantor Fitzgerald, and Stifel maintain positive outlooks with Buy ratings and price targets ranging from $22 to $27. EOLS shares rose 21.24% to $12.50.

Portfolio Pulse from Vandana Singh

January 17, 2024 | 8:55 pm

VNDA

Vanda Pharmaceuticals Inc. has published a study on the efficacy and safety of Iloperidone in treating bipolar mania in the Journal of Clinical Psychiatry. The study's results have been submitted to the FDA as part of a supplemental New Drug Application for Fanapt, with a target action date of April 2, 2024, for the FDA's decision.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 8:48 pm

META

Analysts have provided mixed ratings for Meta Platforms (NASDAQ:META) with 17 reviews in the past three months. The average 12-month price target is $401.35, up 6.79% from the previous target. Analysts' actions include raising and maintaining ratings, with price targets ranging from $350 to $470. Meta's financial performance is strong, with a market cap above industry benchmarks, a revenue growth rate of 23.21%, a net margin of 33.92%, an ROE of 8.37%, an ROA of 5.48%, and a low debt-to-equity ratio of 0.25.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 8:00 pm

DASH

GRUB

UBER

DoorDash is increasing delivery fees in New York City for both customers and restaurants due to a recent minimum wage increase for delivery workers to at least $17.96 per hour. The company informed restaurants of higher commission rates, with a maximum of 23% for delivery and 8% for pickup orders, up from 20% and 5% respectively. The fee cap legislation during the pandemic had set these limits. UberEats has added a $2 'New York Courier fee' and both DoorDash and UberEats have moved the tipping option to post-checkout. Grubhub, DoorDash, and UberEats are involved in ongoing litigation against NYC's fee cap rule. DoorDash now pays delivery workers $29.93 per hour or 50 cents per active minute.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:57 pm

ARMK

Goldman Sachs analyst Lizzie Dove initiated coverage on Aramark (NYSE:ARMK) with a Buy rating and a price target of $33. Dove's analysis suggests that Aramark is at an inflection point for pricing growth due to the typical 18-month lag in passing through inflation in food input prices. The company's exposure to Education, Corrections, and Healthcare segments indicates potential upside in fiscal years 2024-2025. Aramark's net new business has significantly increased, and the trend towards outsourcing is expected to continue, which could lead to positive margin flow-through. Dove also notes that a deceleration in the CPI food away from home index could benefit Aramark's F2024 margin outlook. Additionally, expected rate cuts in 2024 could lower interest costs and increase investor appetite for levered stocks like Aramark. The stock is currently trading slightly lower at $28.85.

Portfolio Pulse from Shivani Kumaresan

January 17, 2024 | 7:52 pm